BIOCHEMICAL MARKERS OF BONE TURNOVER .2. DIAGNOSIS, PROPHYLAXIS, AND TREATMENT OF OSTEOPOROSIS

被引:30
作者
RIIS, BJ
机构
[1] Center for Clinical and Basic Research, Ballerup
关键词
D O I
10.1016/0002-9343(93)90376-Z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a major Stealth problem and is becoming increasingly important in our aging society. In many of the Western countries, patients with hip fracture occupy more hospital beds than patients with any other disease. Measures to combat osteoporosis are urgently needed, but the best way of doing so is uncertain. Osteoporosis prevention can be targeted at a subgroup of the population at high risk of disease. Alternatively; the intervention can be aimed at the entire population. Both preventive strategies have been proposed for osteoporotic fractures. Some researchers advocate population programs to increase weight-bearing exercise and calcium intake or to reduce smoking, but there is little direct evidence of their effectiveness. The most widespread opinion is that bone mass measurement is the most accurate predictor of fracture risk. Prediction of fracture risk may mean treatment for several years with drugs with not only effects, but also adverse effects. This encourages attempts to optimize the diagnostic procedures.
引用
收藏
页码:S17 / S21
页数:5
相关论文
共 34 条
[31]   CYPROTERONE-ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL ESTROGEN GESTAGEN THERAPY [J].
RIIS, BJ ;
JENSEN, J ;
CHRISTIANSEN, C .
CLINICAL ENDOCRINOLOGY, 1987, 26 (03) :327-334
[32]   SERUM LEVELS OF TYPE-I AND TYPE-III PROCOLLAGEN FRAGMENTS IN PAGETS-DISEASE OF BONE [J].
SIMON, LS ;
KRANE, SM ;
WORTMAN, PD ;
KRANE, IM ;
KOVITZ, KL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (01) :110-120
[33]   URINARY-EXCRETION OF PYRIDINIUM CROSSLINKS - A NEW MARKER OF BONE-RESORPTION IN METABOLIC BONE-DISEASE [J].
UEBELHART, D ;
GINEYTS, E ;
CHAPUY, MC ;
DELMAS, PD .
BONE AND MINERAL, 1990, 8 (01) :87-96
[34]  
UEBELHART D, 1991, J CLIN ENDOCR METAB, V66, P88